ClinicalTrials.gov
ClinicalTrials.gov Menu

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study (CMV-IMPACT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01077908
Recruitment Status : Completed
First Posted : March 1, 2010
Last Update Posted : January 25, 2018
Sponsor:
Collaborators:
Wellcome Trust
EMAS Pharma
Commitum AB
BioAnaLab
Information provided by (Responsible Party):
Cell Medica Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2014
  Actual Study Completion Date : October 2014